March 4, 2025 · Form 4 insider transaction
Paravasthu Mukund bought 81,499 shares of NovoCure Limited at $18.19 per share, a transaction worth $1.48M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates.